发明名称 HERPES SIMPLEX VIRUS VACCINES
摘要 The present invention is directed to Herpes simplex-2 viruses that may be used in vaccines to immunize patients against genital herpes.
申请公布号 US2017028058(A1) 申请公布日期 2017.02.02
申请号 US201615201783 申请日期 2016.07.05
申请人 THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 发明人 Yao Feng
分类号 A61K39/245;C12N7/00 主分类号 A61K39/245
代理机构 代理人
主权项 1. A replication-defective, dominant-negative Herpes simplex virus 2 (HSV-2) recombinant virus, comprising within its genome: a) a first sequence encoding a first HSV-2 glycoprotein D (gD2) wherein said sequence is operably linked to a first promoter and said first promoter is operably linked to a first tetracycline operator (Tet-O) sequence; b) optionally, a second sequence encoding a second HSV-2 gD2 wherein said second sequence is operably linked to a second promoter and said second promoter is operably linked to a second tet-O sequence; c) a third sequence encoding a first dominant negative mutant form of HSV-1 or HSV-2 UL9 protein, wherein said third sequence is operably linked to a third promoter and said third promoter is operably linked to a third tetracycline operator (Tet-O) sequence; d) optionally, a fourth sequence encoding a second dominant negative mutant form of HSV-1 or HSV-2 UL9 protein, wherein said fourth sequence is operably linked to a fourth promoter and said fourth promoter is operably linked to a fourth tetracycline operator (Tet-O) sequence; and wherein said genome does not comprise a sequence encoding a functional ICP0 protein.
地址 Boston MA US